Literature DB >> 7902375

CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.

C F Evans1, G F Rall, N Killeen, D Littman, M B Oldstone.   

Abstract

The major host response to many viral infections is the generation of virus-specific CTL. Many protein molecules on the surfaces of both CTL and target cells interact to mediate adhesion of the cells and generate signals that lead to T cell activation and proliferation of virus-specific CTL that then mediate lysis of infected cells. One such protein, CD2, has been shown to increase the binding affinity of CTL to infected cells, and, in addition, enhance CTL activation signals. To determine whether virus-specific CTL could be generated in the absence of CD2, mice lacking a functional CD2 gene were infected with lymphocytic choriomeningitis virus (LCMV), and the responses to the virus were monitored. CD2-deficient mice infected intracerebrally with LCMV died as a consequence of CTL-mediated choriomeningitis, similar to control littermates. Additionally, CD2-deficient mice inoculated i.p. with LCMV cleared the infection by 2 wk postinfection, as did control mice. Viral clearance in these mice was shown to be due to the generation of a vigorous virus-specific MHC-restricted CTL response. Finally, to determine whether CD2 is essential for the generation of memory CTL, we examined the ability of CD2-deficient mice to generate memory CTL to LCMV and found normal memory CTL responses. Our results indicate that CD2 is not required for the generation of an LCMV-specific CTL response in vivo, nor is CD2 required for the maintenance or activation of memory CTL.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902375

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice.

Authors:  J P Christensen; O Marker; A R Thomsen
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection.

Authors:  Nina-N Pawlowski; Daniela Struck; Katja Grollich; Anja-A Kuhl; Martin Zeitz; Oliver Liesenfeld; Jorg-C Hoffmann
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

4.  CD2 sets quantitative thresholds in T cell activation.

Authors:  M F Bachmann; M Barner; M Kopf
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

5.  Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex.

Authors:  M K Wild; A Cambiaggi; M H Brown; E A Davies; H Ohno; T Saito; P A van der Merwe
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

6.  A subtle role for CD2 in T cell antigen recognition.

Authors:  P A van der Merwe
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

Review 7.  CD2 Immunobiology.

Authors:  Christian Binder; Filip Cvetkovski; Felix Sellberg; Stefan Berg; Horacio Paternina Visbal; David H Sachs; Erik Berglund; David Berglund
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

8.  Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Authors:  Hiroyuki Yoneyama; Kenjiro Matsuno; Etsuko Toda; Tetsu Nishiwaki; Naoki Matsuo; Akiko Nakano; Shosaku Narumi; Bao Lu; Craig Gerard; Sho Ishikawa; Kouji Matsushima
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

9.  A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development.

Authors:  Stefan Klein-Hessling; Ronald Rudolf; Khalid Muhammad; Klaus-Peter Knobeloch; Muhammad Ahmad Maqbool; Pierre Cauchy; Jean-Christophe Andrau; Andris Avots; Claudio Talora; Volker Ellenrieder; Isabella Screpanti; Edgar Serfling; Amiya Kumar Patra
Journal:  Nat Commun       Date:  2016-06-17       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.